BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23717474)

  • 21. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
    Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
    Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated Proteomic and Transcriptomic-Based Approaches to Identifying Signature Biomarkers and Pathways for Elucidation of Daoy and UW228 Subtypes.
    Higdon R; Kala J; Wilkins D; Yan JF; Sethi MK; Lin L; Liu S; Montague E; Janko I; Choiniere J; Kolker N; Hancock WS; Kolker E; Fanayan S
    Proteomes; 2017 Feb; 5(1):. PubMed ID: 28248256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
    Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
    Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.
    de Antonellis P; Medaglia C; Cusanelli E; Andolfo I; Liguori L; De Vita G; Carotenuto M; Bello A; Formiggini F; Galeone A; De Rosa G; Virgilio A; Scognamiglio I; Sciro M; Basso G; Schulte JH; Cinalli G; Iolascon A; Zollo M
    PLoS One; 2011; 6(9):e24584. PubMed ID: 21931765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
    Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
    Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles.
    Peyrl A; Krapfenbauer K; Slavc I; Yang JW; Strobel T; Lubec G
    Proteomics; 2003 Sep; 3(9):1781-800. PubMed ID: 12973738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumorsphere Formation Assay: A Cancer Stem-Like Cell Characterization in Pediatric Brain Cancer Medulloblastoma.
    Ray S
    Methods Mol Biol; 2023; 2701():253-259. PubMed ID: 37574488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Proteomic Characterization of a Pediatric Medulloblastoma Xenograft.
    Tsangaris GT; Dimas K; Malamou A; Katsafadou A; Papathanasiou C; Stravopodis DJ; Vorgias CE; Gazouli M; Anagnostopoulos AK
    Cancer Genomics Proteomics; 2017; 14(4):267-275. PubMed ID: 28647700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medulloblastoma stem cells: Promising targets in medulloblastoma therapy.
    Huang GH; Xu QF; Cui YH; Li N; Bian XW; Lv SQ
    Cancer Sci; 2016 May; 107(5):583-9. PubMed ID: 27171351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RBM5 Acts as Tumor Suppressor in Medulloblastoma through Regulating Wnt/β-Catenin Signaling.
    Yu J; Ji G; Shi W; Zhao R; Shen W; Zheng J; Li H; Jiang F
    Eur Neurol; 2020; 83(3):242-250. PubMed ID: 32610314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro characterization of CD133
    Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
    BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity.
    Yu CC; Chiou GY; Lee YY; Chang YL; Huang PI; Cheng YW; Tai LK; Ku HH; Chiou SH; Wong TT
    Childs Nerv Syst; 2010 Jul; 26(7):897-904. PubMed ID: 20179950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The medulloblastoma cell line DAOY but not eleven other tumor cell lines expresses minichromosome maintenance protein 4.
    Gruber-Olipitz M; Yang JW; Stroebel T; Slavc I; Lubec G
    Cancer Lett; 2006 Jul; 238(1):76-84. PubMed ID: 16051427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors.
    Laranjo M; Carvalho MJ; Serambeque B; Alves A; Marto CM; Silva I; Paiva A; Botelho MF
    J Vis Exp; 2020 Mar; (157):. PubMed ID: 32176214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor.
    Cappellari AR; Rockenbach L; Dietrich F; Clarimundo V; Glaser T; Braganhol E; Abujamra AL; Roesler R; Ulrich H; Battastini AM
    PLoS One; 2012; 7(10):e47468. PubMed ID: 23094051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.
    Fang DD; Kim YJ; Lee CN; Aggarwal S; McKinnon K; Mesmer D; Norton J; Birse CE; He T; Ruben SM; Moore PA
    Br J Cancer; 2010 Apr; 102(8):1265-75. PubMed ID: 20332776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.
    Blazek ER; Foutch JL; Maki G
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):1-5. PubMed ID: 17084552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells.
    Gao W; Wu D; Wang Y; Wang Z; Zou C; Dai Y; Ng CF; Teoh JY; Chan FL
    Stem Cell Res Ther; 2018 Sep; 9(1):243. PubMed ID: 30257704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.